title: Effect of low-dose methotrexate on the disposition of glucocorticoids and theophylline.
abstract: Low-dose methotrexate (MTX) therapy has been recently proposed as alternative therapy for patients with severe steroid-requiring asthma. Several questions have been raised regarding the mechanism of action, including alteration of pharmacokinetics of two medications used in these patients, specifically, glucocorticoids and theophylline. To address this question, pharmacokinetic studies were performed at baseline and after 6 weeks of treatment with either intramuscular MTX or placebo (folic acid). Plasma concentrations of theophylline were measured by fluorescence polarization immunoassay (TDx, Abbott Diagnostics, Abbott Park, Ill.). Prednisolone, methylprednisolone, and cortisol concentrations were measured by high-performance liquid chromatography. Fifteen adults were enrolled in the double-blind, placebo-controlled trial. No change in prednisolone pharmacokinetic parameters was found. Theophylline clearance decreased an average of 19% in patients randomized to receive MTX, from 48.0 +/- 2.0 ml/hr/kg to 38.9 +/- 3.6 ml/hr/kg (p less than 0.05). This change resembles change observed with theophylline and phenobarbital clearance in which a high degree of interpatient variability is observed. The most likely explanation for the change in theophylline clearance is inhibition of hepatic microsomal enzyme activity. Three patients complained of adverse effects, and dosage was reduced in one patient. The variable effect of MTX on theophylline clearance indicates that theophylline concentration monitoring should be performed in patients receiving both drugs.
authors.affiliation: Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
authors.forename: A M
authors.initials: AM
authors.lastname: Glynn-Barnhart
authors.forename: S C
authors.initials: SC
authors.lastname: Erzurum
authors.forename: J A
authors.initials: JA
authors.lastname: Leff
authors.forename: R J
authors.initials: RJ
authors.lastname: Martin
authors.forename: J E
authors.initials: JE
authors.lastname: Cochran
authors.forename: G R
authors.initials: GR
authors.lastname: Cott
authors.forename: S J
authors.initials: SJ
authors.lastname: Szefler
mesh_terms: D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D004347:Drug Interactions; D005260:Female; D005938:Glucocorticoids / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008727:Methotrexate / Q000494:pharmacology*; D008875:Middle Aged; D013806:Theophylline / Q000493:pharmacokinetics*
chemical_list: D005938:Glucocorticoids; D013806:Theophylline; D008727:Methotrexate